Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 1.08 | 1.36 |
NAV | ₹10.59 | ₹203.09 |
Fund Started | 14 Oct 2024 | 07 May 2007 |
Fund Size | ₹9.75 Cr | ₹89383.23 Cr |
Exit Load | Exit load of 0.20%, if redeemed within 7 days. | Exit load of 1% if redeemed within 1 year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 5.14% | 8.60% |
3 Year | - | 24.85% |
5 Year | - | 26.49% |
1 Year
3 Year
5 Year
Equity | 99.68% | 93.94% |
Cash | -0.04% | 6.06% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
BSE Ltd. | 2.66% |
Hero Motocorp Ltd. | 1.93% |
Suzlon Energy Ltd. | 1.85% |
Persistent Systems Ltd. | 1.68% |
Dixon Technologies (India) Ltd. | 1.67% |
PB Fintech Ltd. | 1.64% |
Coforge Ltd. | 1.59% |
The Federal Bank Ltd. | 1.55% |
Cummins India Ltd. | 1.53% |
HDFC Asset Management Company Ltd. | 1.52% |
Name | Assets |
|---|---|
Max Financial Services Ltd. | 4.46% |
AU Small Finance Bank Ltd. | 3.70% |
Indian Bank | 3.54% |
The Federal Bank Ltd. | 3.38% |
Balkrishna Industries Ltd. | 3.37% |
Fortis Healthcare Ltd. | 3.19% |
Coforge Ltd. | 3.11% |
Hindustan Petroleum Corporation Ltd. | 2.96% |
Glenmark Pharmaceuticals Ltd. | 2.67% |
Ipca Laboratories Ltd. | 2.52% |
Name | Neeraj Saxena | Chirag Setalvad |
Start Date | 09 May 2025 | 28 Jun 2014 |
Name
Start Date
Description | The scheme seeks to provide investment returns closely corresponding to the total returns of the securities as represented by the Nifty Midcap 150 Total Returns Index before expenses, subject to tracking errors, fees, and expenses | The scheme seeks to provide long-term capital appreciation/income by investing predominantly in Mid-Cap companies. |
Launch Date | 14 Oct 2024 | 07 May 2007 |
Description
Launch Date